Pain Management

Cannabis Use Common in Older Adults With Pain/Arthritis

Most older adults using cannabis report initiating use after the age of 60 years primarily to treat pain.

Number of Waddell Signs Correlate With Steroid Injection Treatment Failure

By

Jessica Nye, PhD

The number of Waddell signs present may indicate future treatment failure.

About Half of Waivered Clinicians Prescribe Buprenorphine for Opioid Use Disorder

About half of waivered clinicians prescribe buprenorphine for opioid use disorder and most treat at levels below their patient limits.

How Successful Are Policies Aimed at Limiting Opioid Prescriptions After Arthroplasty?

By

Brandon May

The percentage of those receiving opioid prescriptions following arthroplasty has increased.

Orphenadrine and Aspirin Combination Now Available for Pain Management

By

Brian Park, PharmD

Orphengesic Forte for the symptomatic relief of mild to moderate pain of acute musculoskeletal disorders is now available.

Targeted Program Can Improve Adherence to Opioid Prescribing Guidelines

A targeted program that allows all prescribers to access real-time data and track and compare their own performance with those of others can improve compliance with opioid prescribing guidelines.

FDA Approves Orphenadrine and Aspirin Combination for Pain Management

The FDA has approved the supplemental Abbreviated New Drug Application (sANDA) for Orphengesic Forte.

Increased Use of Skeletal Muscle Relaxants in the US From 2005 to 2016

From 2005 to 2016, skeletal muscle relaxant (SMR) use increased in the United States.

CDC: 10.7% of US Adults Used Prescription Pain Medications From 2015 to 2018

In 2015 to 2018, 10.7% of US adults aged 20 years or older used one or more prescription pain medications.

Tanezumab Improves Pain, Function in Chronic Low Back Pain

For patients with chronic low back pain, tanezumab 10 mg significantly improves pain and function.

Unapproved Cannabidiol, Curcumin Injectables for Multiple Disorders Recalled

Biota Biosciences announced the voluntary recall of CBD Complex, Curcumin Complex, and Cannabidiol + Curcumin Injectables due to the products being marketed without the approval of the FDA.

FDA Approves NDA for Diclofenac Sodium Topical Gel 1% for Arthritis Pain

Perrigo announced that the FDA has approved the abbreviated New Drug Application for its over-the-counter diclofenac sodium topical gel 1% for the temporary relief of arthritis pain in the hand, wrist, elbow, foot, ankle or knee in adults ≥18 years old.

FDA Approves OTC Combination of Ibuprofen and Acetaminophen for Minor Arthritis Pain

The FDA Advil Dual Action with Acetaminophen for the temporary relief of minor aches and pains due to arthritis and more.

Navigating Patient Pain Under Stricter Opioid Prescribing Laws

Investigators explored concerns with regard to opioid prescribing in compliance with new regulations in a commentary piece.

FDA Approves OTC Switch of Diclofenac Gel, Olopatadine Eye Drops

Diclofenac sodium topical gel and olopatadine HCl ophthalmic drops will soon be available over-the-counter (OTC) after the the Food and Drug Administration (FDA) switched the status of these products from prescription to nonprescription.